“Azeliragon ameliorates Alzheimer’s disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway”, Clinics, vol. 76, p. e2348, Nov. 2021, doi: 10.6061/clinics/2021/e2348.